Atlas Trials

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Clinical trial NCT01297543 · COMPLETED

Trial details

NCT number
NCT01297543
Sponsor
Cellerant Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid LeukemiaMyelodysplasia
Start date
2011-03-01
Primary completion
2014-11-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.